Zhangzhou Pientzehuang Pharmaceutical | 600436 - Cost Of Sales

Stock Price
150.89
Daily Change
-1.92 -1.26%
Monthly
-4.63%
Yearly
-26.75%
Q2 Forecast
147.47

Zz Pientze Pharmaceu reported CNY1.34B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Jiangsu Hengrui CNY 1.17B 86.74M Dec/2025
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Moderna USD 452M 245M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Sh Fosun Pharma CNY 5.57B 492.91M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Wuxi Apptec CNY 6.26B 64.7M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025
Zz Pientze Pharmaceu CNY 1.34B 601.08M Sep/2025